Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rule could help spot dangerous infections in kids after chemo

NCT ID NCT03434795

Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new decision rule to help doctors tell which children with fever and low white blood cells after chemotherapy are at high risk for a serious infection. Researchers looked at 1,900 children aged 1 to 18 with cancer or blood disorders. The goal was to see if the rule works well across many hospitals so doctors can treat kids more safely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,900 people

The number who actually took part.

Start date

May 2012

Finished

May 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with hematology or cancer who consults for febrile neutropenia post-chemotherapy

Ages

1 year to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child aged 1 to 18 years * Child with hematology or cancer * Child with a febrile neutropenia post-chemotherapy * Child with social security * No opposition from the child and/or parents, in case of absence, the holder of the parental authority present, can consent, alone, to the participation of the unemancipated minor. Exclusion Criteria: * Febrile neutropenia at diagnosis of tumor disease * Child with palliative care * Child having had a hematopoietic stem cell allo-graft in the preceding year * Febrile neutropenia immediately post auto-transplant * Antibiotherapy prior to admission * Initial care in a non-investigative center.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Febrile neutropenia, rule of clinical decision, chemotherapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Febrile Neutropenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Febrile neutropenia, rule of clinical decision, chemotherapy

Contacts and locations

Locations

  • Hôpital Jeanne de Flandre - CHRU de Lille

    Lille, France